Carregant...
Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
INTRODUCTION: The introduction of recombinant human erythropoietin revolutionized the management of anemia in patients with chronic kidney disease (CKD). In order to circumvent costly recombinant DNA technology, synthetic chemistry techniques were used to manufacture peginesatide, a synthetic peptid...
Guardat en:
| Publicat a: | Expert Opin Drug Saf |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286458/ https://ncbi.nlm.nih.gov/pubmed/27551882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2016.1218467 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|